窪田製薬ホールディングス(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4596/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2017/08/25 | 日証協 | 290,200株 | -1.39% | 77,700株 | +81.12% | 306,855株 | -0.87% | 4,310株 | +207.86% |
2017/08/18 | 日証協 | 294,300株 | -0.88% | 42,900株 | -1.83% | 309,545株 | -3.88% | 1,400株 | -26.7% |
2017/08/10 | 日証協 | 296,900株 | -1.36% | 43,700株 | -1.8% | 322,045株 | -0.24% | 1,910株 | -76.74% |
2017/08/04 | 日証協 | 301,000株 | -3.06% | 44,500株 | -12.92% | 322,835株 | -1.46% | 8,212株 | +77.52% |
2017/07/28 | 日証協 | 310,500株 | -1.11% | 51,100株 | -43.6% | 327,615株 | -1.64% | 4,626株 | -63.9% |
2017/07/21 | 日証協 | 314,000株 | -1.38% | 90,600株 | +86.04% | 333,089株 | +1.13% | 12,814株 | +72.81% |
2017/07/14 | 日証協 | 318,400株 | -1.27% | 48,700株 | -19.1% | 329,375株 | -0.03% | 7,415株 | -63.83% |
2017/07/07 | 日証協 | 322,500株 | +1.29% | 60,200株 | +10.46% | 329,460株 | +4.7% | 20,500株 | +34.87% |
2017/06/30 | 日証協 | 318,400株 | -8.11% | 54,500株 | +1779.31% | 314,659株 | -8.7% | 15,200株 | +152.7% |
2017/06/23 | 日証協 | 346,500株 | -1.37% | 2,900株 | -95.12% | 344,660株 | -0.2% | 6,015株 | -82.04% |
2017/06/16 | 日証協 | 351,300株 | -4.04% | 59,470株 | -48.21% | 345,345株 | -1.93% | 33,500株 | +74.48% |
2017/06/09 | 日証協 | 366,100株 | +1.5% | 114,830株 | +187.79% | 352,145株 | +2.08% | 19,200株 | +25.49% |
2017/06/02 | 日証協 | 360,700株 | +3.15% | 39,900株 | -71.09% | 344,956株 | +1.26% | 15,300株 | -29.2% |
2017/05/26 | 日証協 | 349,700株 | +13.95% | 138,000株 | +51.15% | 340,661株 | +7.17% | 21,609株 | -13.22% |
2017/05/19 | 日証協 | 306,900株 | +3.37% | 91,300株 | -23.15% | 317,857株 | +3.35% | 24,900株 | -12.63% |
2017/05/12 | 日証協 | 296,900株 | -3.57% | 118,800株 | +2662.79% | 307,557株 | -0.49% | 28,500株 | +547.73% |
2017/05/02 | 日証協 | 307,900株 | -0.1% | 4,300株 | -95.31% | 309,057株 | -0.58% | 4,400株 | -85.58% |
2017/04/28 | 日証協 | 308,200株 | +2.39% | 91,600株 | -26.84% | 310,857株 | +1.01% | 30,510株 | +224.44% |
2017/04/21 | 日証協 | 301,000株 | +1.18% | 125,200株 | +100.64% | 307,747株 | +0.43% | 9,404株 | +67.6% |
※株式分割は考慮していませんのでご注意ください。
Page Top